Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Coloplast A/S
  6. Financials
    COLO B   DK0060448595

COLOPLAST A/S

(COLO B)
  Report
Delayed Nasdaq Copenhagen  -  10:59 2022-11-25 am EST
878.00 DKK   -0.05%
11/18Coloplast Launches New Catheter in the U.S.
GL
11/18Coloplast Launches New Catheter in the U.S.
GL
11/15Coloplast appoints new President of its global Interventional Urology business
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: September 2020 2021 2022 2023 2024 2025
Capitalization1 213 422214 092164 708186 406--
Enterprise Value (EV)1 214 584216 204164 708203 875202 833201 767
P/E ratio 51,0x44,5x35,1x33,7x30,6x27,6x
Yield 1,79%1,89%-2,30%2,49%2,76%
Capitalization / Revenue 11,5x11,0x7,29x7,45x6,90x6,37x
EV / Revenue 11,6x11,1x7,29x8,15x7,51x6,90x
EV / EBITDA 32,0x31,1x21,0x24,0x21,7x19,6x
Price to Book 28,9x26,2x-20,1x16,8x14,9x
Nbr of stocks (in thousands) 212 677212 709212 307212 307--
Reference price (DKK) 1 0041 007776878878878
Announcement Date 11/03/202011/01/202111/07/2022---
1 DKK in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: September 2020 2021 2022 2023 2024 2025
Net sales1 18 54419 42622 57925 02927 00429 249
EBITDA1 6 7056 9477 8408 4799 34610 309
Operating profit (EBIT)1 5 8546 3556 9107 4228 1949 079
Operating Margin 31,6%32,7%30,6%29,7%30,3%31,0%
Pre-Tax Profit (EBT)1 5 4666 2336 1276 9467 9288 720
Net income1 4 1974 8254 7065 4946 0656 690
Net margin 22,6%24,8%20,8%21,9%22,5%22,9%
EPS2 19,722,622,126,028,731,8
Dividend per Share2 18,019,0-20,221,924,2
Announcement Date 11/03/202011/01/202111/07/2022---
1 DKK in Million
2 DKK
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: September 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales1 5 5025 8496 0596 2056 2376 382
EBITDA1 1 9222 0212 0732 2712 0812 062
Operating profit (EBIT)1 1 6861 7611 8142 0461 8241 791
Operating Margin 30,6%30,1%29,9%33,0%29,2%28,1%
Pre-Tax Profit (EBT)1 1 2871 6711 6121 9441 7491 687
Net income1 9801 2891 2301 4741 3711 343
Net margin 17,8%22,0%20,3%23,7%22,0%21,0%
EPS2 4,606,065,796,986,506,35
Dividend per Share ------
Announcement Date 05/05/202208/17/202211/07/2022---
1 DKK in Million
2 DKK
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: September 2020 2021 2022 2023 2024 2025
Net Debt1 1 1622 112-17 47016 42715 361
Net Cash position1 ------
Leverage (Debt / EBITDA) 0,17x0,30x-2,06x1,76x1,49x
Free Cash Flow1 3 9134 371-4 9105 6936 185
ROE (Net Profit / Equities) 58,6%70,0%-61,6%59,4%56,7%
Shareholders' equity1 7 1606 893-8 91510 20511 798
ROA (Net Profit / Asset) 32,0%34,0%-15,8%17,5%18,8%
Assets1 13 11614 211-34 76934 72335 679
Book Value Per Share2 34,838,3-43,652,359,0
Cash Flow per Share2 22,424,9-29,133,336,3
Capex1 846919-1 3391 3361 423
Capex / Sales 4,56%4,73%-5,35%4,95%4,86%
Announcement Date 11/03/202011/01/202111/07/2022---
1 DKK in Million
2 DKK
Previous periodNext period
Estimates
Key data
Capitalization (DKK) 186 405 546 000
Capitalization (USD) 26 056 711 640
Net sales (DKK) 22 579 000 000
Net sales (USD) 3 156 207 016
Number of employees 14 572
Sales / Employee (DKK) 1 549 478
Sales / Employee (USD) 216 594
Free-Float 57,0%
Free-Float capitalization (DKK) 106 341 882 038
Free-Float capitalization (USD) 14 865 007 050
Avg. Exchange 20 sessions (DKK) 172 870 605
Avg. Exchange 20 sessions (USD) 24 164 729
Average Daily Capital Traded 0,09%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA